Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Taskforce On Telehealth Policy Releases Final Recommendations On Safeguarding Virtual Care Beyond Pandemic

Executive Summary

The recommendations include lifting geographic restrictions on originating sites, reinstating HIPAA provisions and eliminating restrictions on telehealth across state lines.

You may also be interested in...



Apple Adds Blood Oxygen Sensor To Apple Watch

The company is sponsoring research on how the blood oxygen sensor feature on its Apple Watch 6 could be applied to specific health problems.

COVID-19 Impact: Young Doctors Rank Telehealth Above AI As Role Support Tool

Under-40s health care professionals’ attitudes have changed during COVID-19, and they want health care system to change too, according to a new report from Royal Philips.

Telehealth: Trump EO Would Extend Payments, While CMS Proposes Permanent Rule

An executive order signed by the US president calls on the Medicare agency to extend telehealth reimbursements beyond the pandemic.

Related Content

Topics

UsernamePublicRestriction

Register

LL111109

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel